Vor Bio to Participate in the Wedbush PacGrow Healthcare Conference

CAMBRIDGE, Mass., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, will host in-person 1x1 investor meetings at the 2023 Wedbush PacGrow Healthcare Conference.

Wedbush PacGrow Healthcare Conference
1x1 Investor Meetings: August 8-9, 2023
Location: Lotte Palace Hotel, New York, NY

About Vor Bio
Vor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit: www.vorbio.com.

Contact:

Media & Investors
Sarah Spencer
+1 857-242-6076
sspencer@vorbio.com


Primary Logo

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  223.24
+0.68 (0.31%)
AAPL  272.88
-1.73 (-0.63%)
AMD  199.23
-9.94 (-4.75%)
BAC  54.53
-0.28 (-0.50%)
GOOG  300.00
-7.73 (-2.51%)
META  655.36
-1.79 (-0.27%)
MSFT  477.96
+1.57 (0.33%)
NVDA  171.85
-5.87 (-3.30%)
ORCL  179.67
-8.98 (-4.76%)
TSLA  469.37
-20.51 (-4.19%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.